Btw @friendlydwarves, fwiw, in 2017 ACR wrote down its Axiron IP to the tune of $10.7m. Ex this, the business would have made a net after-tax profit of $11.8m. Also in that year the business generated FCF of $4.7m. This was low due to a large tax payment in that year amounting to $6.3m - which did not match the actual tax expense for that year. The FCF before tax was $11m which well matches the P&L PBT (before IP impairments), which was $12m.
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux's fifth generic dossier accepted by FDA for review
Ann: Acrux's fifth generic dossier accepted by FDA for review, page-21
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.18M |
Open | High | Low | Value | Volume |
6.6¢ | 6.6¢ | 6.6¢ | $1.702K | 25.78K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 86194 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 41204 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 86194 | 0.066 |
2 | 42846 | 0.065 |
1 | 71240 | 0.064 |
2 | 81558 | 0.063 |
1 | 100000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.067 | 41204 | 3 |
0.069 | 14507 | 1 |
0.070 | 107594 | 3 |
0.072 | 30000 | 1 |
0.073 | 12624 | 1 |
Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |